|
LRP8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.322100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.423180E-03 |
| Normal-vs-Stage2 |
8.389900E-04 |
| Normal-vs-Stage3 |
3.071200E-01 |
| Normal-vs-Stage4 |
5.423000E-01 |
| Stage1-vs-Stage2 |
8.870600E-01 |
| Stage1-vs-Stage3 |
2.863900E-02 |
| Stage1-vs-Stage4 |
4.177800E-04 |
| Stage2-vs-Stage3 |
1.418140E-02 |
| Stage2-vs-Stage4 |
3.950900E-04 |
| Stage3-vs-Stage4 |
1.052770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.557800E-03 |
| Normal-vs-AfricanAmerican |
9.988000E-01 |
| Normal-vs-Asian |
6.772400E-01 |
| Caucasian-vs-AfricanAmerican |
3.335800E-01 |
| Caucasian-vs-Asian |
3.785400E-01 |
| AfricanAmerican-vs-Asian |
7.541800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.281900E-03 |
| Normal-vs-Female |
2.268800E-01 |
| Male-vs-Female |
2.915800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.696400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.080400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.600370E-01 |
| Normal-vs-Age(81-100Yrs) |
9.922900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.552600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.189800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.159800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.290420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.493400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.549570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.88639999953999E-07 |
| Normal-vs-Grade 2 |
5.63719999999712E-05 |
| Normal-vs-Grade 3 |
5.084300E-02 |
| Normal-vs-Grade 4 |
2.506300E-02 |
| Grade 1-vs-Grade 2 |
7.136900E-03 |
| Grade 1-vs-Grade 3 |
5.646100E-04 |
| Grade 1-vs-Grade 4 |
1.28260002618674E-09 |
| Grade 2-vs-Grade 3 |
4.911700E-02 |
| Grade 2-vs-Grade 4 |
8.80310000450635E-08 |
| Grade 3-vs-Grade 4 |
1.205550E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.59039999947375E-07 |
| Normal-vs-ccB subtype |
8.091200E-01 |
| ccA subtype-vs-ccB subtype |
1.56579999965878E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.947170E-01 |
| Normal-vs-N1 |
1.047830E-01 |
| N0-vs-N1 |
1.062400E-02 |
|
|
